AMC
AMC Entertainment Holdings, Inc.
AMC has the edge over CHTR overall, supported by stronger modeled upside and stronger fundamentals.
CHTR
Charter Communications, Inc.
CHTR trails on the overall score without a compensating advantage in the available component scores.
AMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Under pressure |
AMC's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is under pressure.
CHTR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weak |
CHTR's revenue, profitability and cash flow are currently stable, but its balance sheet is weak.
AMC PE Valuation
AMC has no meaningful PE right now: it lost money over the past year.
CHTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.1x | $133 | — |
| Cheap | 7.3x | $69.62 | -48% |
| Fair | 12x | $118 | -11% |
| Current | 14x | $133 | — |
| Expensive | 42x | $404 | +205% |
Historical ranges are pointers, not guarantees.
CHTR's PE is in its fair range at 14x. If earnings grow as analysts expect, today's price would be 3.1x next year's earnings, in its cheap range.
AMC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
AMC has the edge over CHTR on the outlook, with more favorable profitability expectations.
CHTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CHTR, but weaker profitability. However, they disagree widely on these estimates.
AMC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.40 | +$0.94 |
| Q2 2026 | -$1.10 | -$0.28 |
| Q1 2026 | -$1.09 | -$0.18 |
| Q4 2025 | -$1.34 | -$0.28 |
| Q3 2025 | -$1.34 | +$0.29 |
| Q2 2025 | -$0.82 | +$0.67 |
| Q1 2025 | -$0.91 | +$0.38 |
| Q4 2024 | -$1.06 | +$1.31 |
AMC lost $0.40 per share over the past year, a smaller loss than the year before.
CHTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $42.65 | +344% |
| Q3 2026 | $9.60 | -73% |
| Q2 2026 | $38.44 | +5.2% |
| Q1 2026 | $36.96 | +3.1% |
| Q4 2025 | $36.21 | +3.5% |
| Q3 2025 | $36.05 | +13% |
| Q2 2025 | $36.53 | +17% |
| Q1 2025 | $35.84 | +16% |
| Q4 2024 | $34.97 | +17% |
CHTR has the edge over AMC on earnings quality, reporting a profit while its opponent remains loss making.
AMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +32% |
| Q2 2026 | $1.6B | +14% |
| Q1 2026 | $1B | +21% |
| Q4 2025 | $1.3B | -1.4% |
| Q3 2025 | $1.3B | -3.6% |
| Q2 2025 | $1.4B | +36% |
| Q1 2025 | $862.5M | -9.3% |
| Q4 2024 | $1.3B | +18% |
AMC has the edge over CHTR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +12 points |
| Q2 2026 | 15% | +8.3 points |
| Q1 2026 | -4.4% | +13 points |
| Q4 2025 | 0% | -0.3 points |
| Q3 2025 | 2.8% | -2.6 points |
| Q2 2025 | 6.6% | +11 points |
| Q1 2025 | -17% | -5.5 points |
| Q4 2024 | 0.4% | +14 points |
AMC has the edge over CHTR on profitability, with a higher operating margin.
CHTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $14.9B | +9.1% |
| Q2 2026 | $13.5B | -1.7% |
| Q1 2026 | $13.6B | -1% |
| Q4 2025 | $13.6B | -2.3% |
| Q3 2025 | $13.7B | -0.9% |
| Q2 2025 | $13.8B | +0.6% |
| Q1 2025 | $13.7B | +0.4% |
| Q4 2024 | $13.9B | +1.6% |
CHTR's revenue grew through 2021 and has held roughly level since: $14.9B last quarter, up 9.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -24% | -47 points |
| Q2 2026 | 23% | -1.2 points |
| Q1 2026 | 24% | 0 points |
| Q4 2025 | 24% | -0.4 points |
| Q3 2025 | 23% | -1.3 points |
| Q2 2025 | 24% | 0 points |
| Q1 2025 | 24% | +0.7 points |
| Q4 2024 | 24% | +0.5 points |
CHTR's operating margin was −24% last quarter, down 47 points from the same quarter a year ago, near the bottom of its range since 2019.
AMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $109.3M | +$190.4M |
| Q2 2026 | $190.1M | +114% |
| Q1 2026 | -$174.7M | +$242.3M |
| Q4 2025 | $43.3M | -62% |
| Q3 2025 | -$81.1M | +$11.1M |
| Q2 2025 | $88.9M | +$168.1M |
| Q1 2025 | -$417M | -$178.2M |
| Q4 2024 | $113.9M | +$263.8M |
AMC has the edge over CHTR on cash flow, with more consistent year-over-year improvement.
CHTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1B | -30% |
| Q2 2026 | $1.1B | +45% |
| Q1 2026 | $1.4B | -21% |
| Q4 2025 | $426M | +7% |
| Q3 2025 | $1.4B | +6.5% |
| Q2 2025 | $726M | -27% |
| Q1 2025 | $1.8B | +336% |
| Q4 2024 | $398M | -60% |
CHTR's free cash flow has been positive every quarter for seven years: $3.9B over the past year, down 11% from the year before.
AMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +24% | +175M shares |
| 1 year | +107% | +463M shares |
| 3 years | +767% | +793M shares |
| 5 years | +4063% | +875M shares |
AMC has 897M diluted shares, up 107% from a year ago.
CHTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.6% | -4.3M shares |
| 1 year | -14% | -19.5M shares |
| 3 years | -23% | -35.1M shares |
| 5 years | -38% | -70.2M shares |
| Available history | -46% | -101M shares |
CHTR has the edge over AMC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $21M |
| Q2 2026 | $852M |
| Q1 2026 | $1B |
| Q4 2025 | $766M |
| Q3 2025 | $2.1B |
| Q2 2025 | $1.5B |
| Q1 2025 | $802M |
| Q4 2024 | $114M |
CHTR spent $2.7B buying back its own shares over the past year, down 41% from the year before.
AMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 9.2x | High |
| Q4 2025 | 12.2x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 10.7x | High |
| Q1 2025 | 18.6x | High |
| Q4 2024 | 14.3x | High |
AMC has the edge over CHTR on leverage, with a lower net debt burden relative to earnings.
CHTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.0x | High |
| Q2 2026 | 4.4x | High |
| Q1 2026 | 4.3x | High |
| Q4 2025 | 4.4x | High |
| Q3 2025 | 4.4x | High |
| Q2 2025 | 4.3x | High |
| Q1 2025 | 4.3x | High |
| Q4 2024 | 4.3x | High |
CHTR's net debt is about 7.0 years of its operating earnings (EBITDA), up from 4.4 years a year ago.
AMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.3 | Neutral |
| Stochastic | 65.4 | Neutral |
AMC's weekly RSI is 67 (neutral) and its Stochastic is 65 (neutral).
CHTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.5 | Neutral |
| Stochastic | 32.9 | Neutral |
CHTR's weekly RSI is 47 (neutral) and its Stochastic is 33 (neutral).
AMC PE vs Communication Services Sector
AMC has no meaningful PE right now: it lost money over the past year.
CHTR PE vs Communication Services Sector
| Metric | CHTR | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 16x | 16% below |
| PE % | 57 | 26 | 31 pts above |
CHTR is trading at 14x earnings, a 16% discount to the Communication Services sector's median of 16x.
AMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.01 | 11% above |
| 20 week MA | $2.64 | 27% above |
| 50 week MA | $2.01 | 66% above |
| 100 week MA | $2.53 | 32% above |
| 200 week MA | $10.9 | 69% below |
AMC has the edge over CHTR on trend strength, trading above more of its moving averages.
CHTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $113.3 | 17% above |
| 20 week MA | $130.5 | 1.6% above |
| 50 week MA | $168.2 | 21% below |
| 100 week MA | $247.3 | 46% below |
| 200 week MA | $300.4 | 56% below |
CHTR has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 56% below its 200-week average.
AMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $12.6 | -66% |
| 2021 | $12.6 | $142.6 | +1036% |
| 2022 | $142.6 | $44.0 | -69% |
| 2023 | $44.0 | $6.12 | -86% |
| 2024 | $6.12 | $4.00 | -35% |
| 2025 | $4.00 | $1.69 | -58% |
| 2026 YTD | $1.69 | $3.34 | +98% |
AMC has the edge over CHTR on returns for 2026, with the stronger performance.
CHTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $483.7 | $656.5 | +36% |
| 2021 | $656.5 | $648.3 | -1.2% |
| 2022 | $648.3 | $333.9 | -48% |
| 2023 | $333.9 | $388.7 | +16% |
| 2024 | $388.7 | $348.7 | -10% |
| 2025 | $348.7 | $207.2 | -41% |
| 2026 YTD | $207.2 | $132.7 | -36% |
CHTR has finished lower in four of the last six years. It's down 36% so far in 2026.